Comparison of Ultrasound-guided Intraarticular Hip Injections With and Without Prior Local Anesthesia
1 other identifier
interventional
42
1 country
1
Brief Summary
In this single-center randomized controlled trial, subjects undergoing a first-time ultrasound-guided unilateral intraarticular hip injection will be randomized into one of two groups: hip injection with prior local anesthesia (With LA) or hip injection without prior local anesthesia (Without LA). Visual analog scale (VAS) pain scores (0-100) will be collected after the local anesthesia injection (With LA group) and intraarticular hip injection (both groups). The primary outcome measure for comparison between the two groups will be VAS score for the intraarticular hip injection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 12, 2022
CompletedFirst Posted
Study publicly available on registry
January 26, 2022
CompletedStudy Start
First participant enrolled
June 30, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 10, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 10, 2023
CompletedJune 27, 2023
June 1, 2023
10 months
January 12, 2022
June 24, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
mean pain score
A visual analog pain score will be collected. The scale of the score is 0-100 with 100 indicating more pain.
baseline
Study Arms (2)
Hip injection with prior local anesthesia
ACTIVE COMPARATORHip injection without prior local anesthesia
ACTIVE COMPARATORInterventions
All intraarticular hip injections will be performed under real-time ultrasound guidance using a GE LOGIQ P9 ultrasound machine with a C1-5-RS 1-5 MHz curvilinear transducer (GE Healthcare, Chicago, IL, USA). For the procedure, patients will be placed in a supine position. The curvilinear transducer and ultrasound machine will be used to visualize the anterior aspect of the hip joint in a sagittal oblique plane. Sterile technique will be used to perform the procedure.
Eligibility Criteria
You may qualify if:
- patients undergoing a first-time ultrasound-guided unilateral intraarticular hip injection
- Subjects must be fluent in English
- Subject must be able to consent for themselves and mark pain levels on a visual analog scale.
You may not qualify if:
- previous intraarticular hip injection (to remove bias from prior injection experiences)
- prior surgery on the hip to be injected
- use of opioid medication on the day of or day before the procedure
- diabetes mellitus
- body mass index (BMI) greater than 40
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Rochester Medical Center Physical Medicine and Rehabilitation
Rochester, New York, 14618, United States
Related Publications (1)
Lazaro RM, Smith JM, Bender N, Punreddy A, Barford N, Paul JH. Comparison of Pain With Ultrasound-Guided Intra-Articular Hip Injections With and Without Prior Subcutaneous Local Anesthesia. Clin J Sport Med. 2024 Jul 24;35(5):543-548. doi: 10.1097/JSM.0000000000001260.
PMID: 39046314DERIVED
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- CARE PROVIDER
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
January 12, 2022
First Posted
January 26, 2022
Study Start
June 30, 2022
Primary Completion
May 10, 2023
Study Completion
May 10, 2023
Last Updated
June 27, 2023
Record last verified: 2023-06
Data Sharing
- IPD Sharing
- Will not share